foxo4 dri senolytic peptide human trial 2024 2025

foxo4 dri senolytic peptide human trial 2024 2025 FOXO4-DRI UK | Research foxo4-dri senolytic peptide human trial

Name: foxo4 dri senolytic peptide human trial 2024 2025 FOXO4-DRI UK | Research foxo4-dri senolytic peptide human trial
Brand: trustt.digital
SKU: 33820717765
Price: 25.80 USD
Availability: InStock
Rating: 4.5886000000000005 (26 reviews)

foxo4 dri senolytic peptide human trial 2024 2025 regulates endothelial cell senescence via the P53 signaling pathway FOXO4 DRI Beverly Hills Rejuvenation Frontiers FOXO4 DRI regulates endothelial cell senescence via the P53 signaling pathway Targeting Cellular Senescence in Aging and Age Related Diseases: Challenges, Considerations, and the Emerging Role of Senolytic and Senomorphic Therapies Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect

SKU: 33820717765 · From trustt.digital

4.6

USD25.80 USD53.80

Pay in 4 interest-free payments of $6.45 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Fagiani F, Pedrini E, Martire MS et al (2025) Spatially-restricted inflammation-induced senescent-like glia in multiple sclerosis and patient-derived organoids

The peptide also promotes polarization of macrophages from pro-inflammatory M1 phenotypes toward tissue-repairing M2 phenotypes, with treated macrophages showing 70% increased phagocytic activity for clearing inflammatory debris and 3-fold higher production of VEGF compared to untreated controls

This is how we deliver care with intention, accountability, and a higher standard than transactional telehealth models

GMP certified / 99% HPLC purity / Pan-India delivery / Cash on Delivery available Research Use Only This product is intended solely for laboratory and research purposes